Bard® InLay® Ureteral Stent with NiCore™ Guidewire 776424Recalls & reported problems
C. R. Bard, Inc. · INLAY URETERAL STENT W/NITINOL GUIDEWIRE · Class 2 · Implant
All models of Bard InLay Ureteral Stent with NiCore Guidewire (7)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 10801741014199), received between Jan 21, 2022 and Apr 4, 2026 — classified as 2 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Patient Device Interaction Problem” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Patient Device Interaction Problem2
- Adverse Event Without Identified Device or Use Problem1
- Biocompatibility1
- Calcified1
- Partial Blockage1
Patient problems
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available2
- No Clinical Signs, Symptoms or Conditions2
- Discomfort1
- Pain1
- Unspecified Infection1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryApr 4, 2026Adverse Event Without Identified Device or Use Problem; Patient Device Interaction Problem
CRITICAL CARE NURSES REPORTED IN AN ONLINE SURVEY STATED THAT IN CHART 3, IN THE ONLINE SURVEY A DR. IN QUESTION: "PLEASE SPECIFY IF ANY OF THE FOLLOWING ADVERSE EVENTS OCCURRED AS A RESULT OF THE DEVICE (I.E. PLEASE INDICATE IF THE PATIENT EXPERIENCED ANY DEVICE RELATED ADVERSE EVENTS). " SHE/HE ANSWERED THE FOLLOWING AES: CHART 3- URETERAL REFLUX, PAIN/DISCOMFORT, INFECTION, HEMATURIA. ALSO, THE RESPONDENT IN QUESTION "DID THE URETERAL REFLUX, PAIN/DISCOMFORT, INFECTION, HEMATURIA RESULT IN PATIENT INJURY REQUIRING MEDICAL OR SURGICAL INTERVENTION? OF NOTE: ANY ACTION AS A RESULT OF AN ADVERSE EVENT IS CONSIDERED MEDICAL INTERVENTION (E.G. PRESCRIBING ANY MEDICATION AS A RESULT OF AN ADVERSE EVENT, SURGERY AS A RESULT OF AN ADVERSE EVENT, ETC.)" SHE/HE ANSWERED WITH "NO" IN ALL LOOPS. IN ADDITION, IN QUESTION "DID THE PATIENT EXPERIENCE ANY OF THE FOLLOWING COMPLICATIONS PRIOR TO DEVICE PLACEMENT OF INLAY URETERAL STENT WITH NICORE GUIDEWIRE?" SHE/HE ANSWER WITH THE FOLLOWING COMPLICATIONS: URINARY SYMPTOMS, HEMATURIA. THE CODE OF PRODUCT IS CHART 3- 776424.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Discomfort; Pain
MAUDE report 24785555 ↗InjuryJan 21, 2022Biocompatibility; Patient Device Interaction Problem; Biocompatibility; Patient Device Interaction Problem
IT WAS REPORTED THAT THE USER EXPERIENCED STONE FORMATION, URETERAL REFLUX, INFECTION, AND URINARY SYMPTOMS, OCCLUSION, STENT ENCRUSTATION WHILE USING THE URETERAL STENT. MEDICAL INTERVENTION WAS UNKNOWN
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Unspecified Infection
MAUDE report 13314132 ↗MalfunctionJan 21, 2022Partial Blockage; Partial Blockage
IT WAS REPORTED THAT THE USER EXPERIENCED STONE FORMATION, URETERAL REFLUX, INFECTION AND URINARY SYMPTOMS, OCCLUSION, STENT ENCRUSTATION WHILE USING THE URETERAL STENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13314130 ↗MalfunctionJan 21, 2022Calcified; Calcified
IT WAS REPORTED THAT THE USER EXPERIENCED STONE FORMATION AND STENT ENCRUSTATION, URETERAL REFLUX, INFECTION, AND URINARY SYMPTOMS, OCCLUSION WHILE USING THE URETERAL STENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13314064 ↗
Other STENT, URETERAL devices
- Bard® InLay Optima® Ureteral Stent 788426C. R. Bard, Inc. · STENT, URETERAL1 recall100 reports
- Bard® InLay Optima® Ureteral Stent 788626C. R. Bard, Inc. · STENT, URETERAL122 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777626C. R. Bard, Inc. · STENT, URETERAL118 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777426C. R. Bard, Inc. · STENT, URETERAL108 reports
- Bard® InLay® Ureteral Stent 778626C. R. Bard, Inc. · STENT, URETERAL100 reports
- Percuflex™ Plus M0061752530Boston Scientific Corporation · STENT, URETERAL1 death99 reports
- Contour VL™ M0061801560Boston Scientific Corporation · STENT, URETERAL1 recall45 reports
- Polaris™ Ultra M0061921330Boston Scientific Corporation · STENT, URETERAL71 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page